These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 22528594)

  • 1. Diabetes mellitus and acute coronary syndrome: lessons from randomized clinical trials.
    Sethi SS; Akl EG; Farkouh ME
    Curr Diab Rep; 2012 Jun; 12(3):294-304. PubMed ID: 22528594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary treatment of unstable angina and non-ST-segment-elevation myocardial infarction (part 2).
    Sami S; Willerson JT
    Tex Heart Inst J; 2010; 37(3):262-75. PubMed ID: 20548800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based medical therapy of patients with acute coronary syndromes.
    Ramanath VS; Eagle KA
    Am J Cardiovasc Drugs; 2007; 7(2):95-116. PubMed ID: 17503881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.
    Toth PP
    Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention.
    Mehta SR; Yusuf S
    J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):79S-88S. PubMed ID: 12644345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute coronary syndromes and diabetes mellitus.
    Foussas SG
    Hellenic J Cardiol; 2016; 57(5):375-377. PubMed ID: 28302514
    [No Abstract]   [Full Text] [Related]  

  • 7. Optimizing antiplatelet therapy for the ACS patient: reacting to clinical trial data from the ISAR-REACT-2 studies.
    Steinhubl SR
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S12-9. PubMed ID: 17224886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet intervention in acute coronary syndrome.
    Arora RR; Rai F
    Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes and acute coronary syndromes.
    Roffi M; Eberli FR
    Best Pract Res Clin Endocrinol Metab; 2009 Jun; 23(3):305-16. PubMed ID: 19520305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute coronary syndrome in the patient with diabetes: is the management different?
    Amin AP; Marso SP
    Curr Cardiol Rep; 2010 Jul; 12(4):321-9. PubMed ID: 20446120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modern treatment in acute coronary syndrome].
    Bauer T; Zahn R
    Dtsch Med Wochenschr; 2012 Apr; 137(14):722-5. PubMed ID: 22454203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet therapy in patients with diabetes mellitus and acute coronary syndrome.
    Patti G; Proscia C; Di Sciascio G
    Circ J; 2014; 78(1):33-41. PubMed ID: 24334561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes and acute coronary syndrome.
    Keller PF; Carballo D; Roffi M
    Minerva Med; 2010 Apr; 101(2):81-104. PubMed ID: 20467408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Oral Anticoagulants in Addition to Antiplatelet Therapy for Secondary Prevention after Acute Coronary Syndromes: a Review.
    Khalil P; Kabbach G
    Curr Cardiol Rep; 2019 Jan; 21(1):5. PubMed ID: 30689068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic therapy in patients with coronary artery disease and with type 2 diabetes mellitus.
    Farhan S; Höchtl T; Kautzky-Willer A; Wojta J; Huber K
    Wien Med Wochenschr; 2010 Jan; 160(1-2):30-8. PubMed ID: 20229159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes.
    Bosch X; Marrugat J; Sanchis J
    Cochrane Database Syst Rev; 2013 Nov; (11):CD002130. PubMed ID: 24203004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of angiographic lesion complexity in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the acute catheterization and urgent intervention triage strategy trial).
    Goto K; Lansky AJ; Ng VG; Pietras C; Nargileci E; Mehran R; Parise H; Feit F; Ohman EM; White HD; Bertrand ME; Desmet W; Hamon M; Stone GW
    Am J Cardiol; 2014 Dec; 114(11):1638-45. PubMed ID: 25312637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial.
    Wiviott SD; White HD; Ohman EM; Fox KA; Armstrong PW; Prabhakaran D; Hafley G; Lokhnygina Y; Boden WE; Hamm C; Clemmensen P; Nicolau JC; Menozzi A; Ruzyllo W; Widimsky P; Oto A; Leiva-Pons J; Pavlides G; Winters KJ; Roe MT; Bhatt DL
    Lancet; 2013 Aug; 382(9892):605-13. PubMed ID: 23953385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the role of thrombin in the pathogenesis of recurrent ischaemia after acute coronary syndrome.
    Weitz JI
    Thromb Haemost; 2014 Nov; 112(5):924-31. PubMed ID: 25030773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromes.
    Braunwald E; Angiolillo D; Bates E; Berger PB; Bhatt D; Cannon CP; Furman MI; Gurbel P; Michelson AD; Peterson E; Wiviott S
    Clin Cardiol; 2008 Mar; 31(3 Suppl 1):I2-9. PubMed ID: 18481818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.